Instead of pushing to the full weight-loss dose, some patients start at a low dose, just enough to nudge the metabolic and inflammatory pathways, without major appetite suppression
Her nausea dropped by 50%
Key Takeaways GLP-1 receptor agonists have evolved from diabetes medications into essential cardiovascular drugs, offering proven protection against heart attacks, strokes, and cardiovascular death across diverse patient populations
Process Initial consultation This is the first step in starting
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
Initial Training During your first visit or medication start, Brenda Johnson and her clinical team will show you exactly how to use the injection pen, including: How to prepare the dose How to choose and rotate injection sites How to avoid common mistakes 2